Groton, CT, United States of America

Katherine E Brighty

This inventor holds 15 USPTO granted patents, primarily in Antibiotic Development. Top assignee: Pfizer Corporation. Active years: 1987-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katherine E Brighty. Retrieved from https://idiyas.com/inventor/katherine-e-brighty

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 1.7

ph-index = 6

Forward Citations = 108(Granted Patents)


Company Filing History:


Years Active: 1987-2010

Loading Chart...
Areas of Expertise:
Penem Prodrugs
Hygromycin Derivatives
Macrolide Antibiotics
Aza Bicyclo Compounds
Anti-Bacterial Agents
Quinolone Carboxylic Acids
Thiazolyl Substituted Compounds
Oxazolyl Piperidyl
Heterocyclic Acids
Synthesis Processes
Carboxylate Esters
15 patents (USPTO):Explore Patents

Title: Katherine E Brighty: Innovator in Pharmaceutical Science

Introduction

Katherine E Brighty is a prominent inventor based in Groton, CT (US). She has made significant contributions to the field of pharmaceutical science, particularly in the development of prodrugs. With a total of 15 patents to her name, her work has had a substantial impact on the treatment and prevention of infections in mammals, including humans.

Latest Patents

Among her latest patents is the innovative work on Penem prodrugs, which are orally bioavailable prodrugs of sulopenem. This invention includes solvates and hydrates thereof, along with their preparation, formulation, and use to treat and prevent infections in mammals. The abstract of this patent emphasizes that it is not limiting to the invention, showcasing the potential for further advancements in this area.

Career Highlights

Katherine has built a successful career at Pfizer Corporation, where she has been instrumental in advancing pharmaceutical research and development. Her expertise in creating effective drug formulations has positioned her as a key player in the industry.

Collaborations

Throughout her career, Katherine has collaborated with notable colleagues, including Paul R McGuirk and John Adams Lowe, III. These partnerships have fostered innovation and have contributed to the success of her projects.

Conclusion

Katherine E Brighty is a remarkable inventor whose work in pharmaceutical science continues to influence the field. Her dedication to developing effective treatments demonstrates her commitment to improving health outcomes for individuals worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…